Search Results - "Kuczynski, Kriste"

A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic by Pettifor, Audrey, DiPrete, Bethany L, Shook-Sa, Bonnie E, Premkumar, Lakshmanane, Kuczynski, Kriste, Dittmer, Dirk, Aiello, Allison, Wallet, Shannon, Maile, Robert, Tan, Joyce, Jadi, Ramesh, Pluta, Linda, de Silva, Aravinda M, Weber, David J, Kim, Min, Seña, Arlene C, Jones, Corbin D

“…Early in the pandemic, transmission risk from asymptomatic infection was unclear, making it imperative to monitor infection in workplace settings. Further,…”
Get full text

Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331] by Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.

Get full text

HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption by Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.

“…Early-phase HIV remission (“cure”) trials aim to test interventions developed to eradicate HIV or to sustainably control HIV without antiretroviral treatment…”
Get full text

A Paradigm of Investigator Duty to Multiple Stakeholder Participants by Foss, Kimberly, Henderson, Gail E., Kuczynski, Kriste, Roberts, Megan Clarke

Get full text

The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research by Conley, John M., Cadigan, R. Jean, Davis, Arlene M., Juengst, Eric T., Kuczynski, Kriste, Major, Rami, Stancil, Hayley, Villa-Palomino, Julio, Waltz, Margaret, Henderson, Gail E.

“…This paper analyses the activities of five organizations shaping the debate over the global governance of genome editing in order to assess current approaches…”
Get full text

Recommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: report from a participatory workshop by Peay, Holly L, Ormsby, Nuchanart Q, Henderson, Gail E, Jupimai, Thidarat, Rennie, Stuart, Siripassorn, Krittaecho, Kanchawee, Kunakorn, Isaacson, Sinéad, Cadigan, R Jean, Kuczynski, Kriste, Likhitwonnawut, Udom

“…Abstract Background The social/behavioral HIV Decision-Making Study (DMS) assesses informed consent and trial experiences of individuals in HIV remission…”
Get full text

Perceptions of patients with inflammatory bowel diseases on biobanking by Long, Millie D, Cadigan, R Jean, Cook, Suzanne F, Haldeman, Kaaren, Kuczynski, Kriste, Sandler, Robert S, Martin, Christopher F, Chen, Wenli, Kappelman, Michael D

“…Little is known about beliefs, understanding, and perceptions of biobanking among patients with inflammatory bowel diseases. We aimed to further understand…”
Get full text

Su1327 Keep or Destroy? Attitudes of Patients With Inflammatory Bowel Diseases on Biospecimen Handling at Biobank Closure by Cadigan, R. Jean, Kappelman, Michael, Gulati, Ajay S, Cook, Suzanne, haldeman, kaaren, Kuczynski, Kriste, Sandler, Robert S, Martin, Christopher F, Chen, Wenli, Long, Millie D

Get full text

P-064 Perceptions of Patients with Inflammatory Bowel Diseases on Biobanking in the CCFA Partners Cohort by Long, Millie, Cadigan, Jean, Cook, Suzanne, Kaufman, David, Kuczynski, Kriste, Haldeman, Kaaren, Sandler, Robert, Martin, Christopher, Chen, Wenli, Kappelman, Michael

Get full text

A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic by Audrey Pettifor, Bethany L. DiPrete, Bonnie E. Shook-Sa, Lakshmanane Premkumar, Kriste Kuczynski, Dirk Dittmer, Allison Aiello, Shannon Wallet, Robert Maile, Joyce Tan, Ramesh Jadi, Linda Pluta, Aravinda M. de Silva, David J. Weber, Min Kim, Arlene C. Seña, Corbin D. Jones

“…Background Early in the pandemic, transmission risk from asymptomatic infection was unclear, making it imperative to monitor infection in workplace settings…”
Get full text